Concepedia

In vivo cervical cancer growth inhibition by genetically engineered cytotoxic T cells

Peter Dall, Isabell Herrmann, Bettina Durst, Mariam A. Stoff‐Khalili, Gerd Bauerschmitz, Bettina Hanstein, Dieter Niederacher

Cancer Immunology Immunotherapy · 2004 · 28 citations · 26 references

DOIFull text

Open access

Concepts

References

26

Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line

Jay P. Morgenstern, Hartmut Land · Nucleic Acids Research · 1990 · 2.1K citations · Full text

, , +15

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

Steven A. Rosenberg, James Chih‐Hsin Yang, Douglas J. Schwartzentruber et al. · Nature Medicine · 1998 · 1.8K citations

, , +16

Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.

Carlos L. Arteaga, Stephen D. Hurd, Angela R. Winnier et al. · Journal of Clinical Investigation · 1993 · 358 citations · Full text

, , +17

Tumor-induced interleukin 10 suppresses the ability of splenic dendritic cells to stimulate CD4 and CD8 T-cell responses.

Arvin Yang, Edmund C. Lattime · PubMed · 2003 · 165 citations

, , +17

Surface protein expression and messenger RNA-splicing analysis of CD44 in uterine cervical cancer and normal cervical epithelium.

Peter Dall, Karl‐Heinz Heider, Armin Hekele et al. · PubMed · 1994 · 124 citations

, , +17